TLDR:
- Courier Health, a NYC-based technology company specializing in chronic conditions or rare diseases, raised $16.5M in Series A funding.
- The funding round was led by Norwest Venture Partners with participation from existing investor Work-Bench.
Courier Health, a technology company based in New York City, recently announced that they have raised $16.5 million in Series A funding. The funding round was led by Norwest Venture Partners, with existing investor Work-Bench also participating. The company plans to use the funds to support product innovation and expand their team in order to bring their customer relationship management (CRM) platform to more biopharma partners.
Founded by Danny Sigurdson, Courier Health specializes in providing a patient-based CRM platform specifically designed for biopharma field access, patient services, and marketing teams. Their platform offers centralized patient and provider management, workflow automation, and advanced analytics. This innovative solution aims to personalize the patient journey and improve coordination between various stakeholders involved in healthcare.
This latest funding round signifies a vote of confidence in Courier Health’s approach and their potential to make a significant impact in the healthcare industry. The company’s focus on chronic conditions and rare diseases highlights the growing need for specialized solutions in healthcare management and patient care.
